Summary
UVALITH proposes to advance optical frequency conversion technology developed for the FET Proactive project QUIC
(Quantum Simulation of Insulators and Conductors) toward industrial and biomedical use. Optical frequency converters use
nonlinear optical processes such as second harmonic generation to produce coherent light at wavelengths that are not
available, or not efficient, with existing laser sources. Importantly, optical frequency converters can reach near-ultraviolet
(UVA) wavelengths, employed in biological and medical applications based on fluorescent biomarkers. In QUIC, we have
developed a monolithic frequency converter, in which a single nonlinear optical crystal acts simultaneously as an optical
resonator, frequency converter, and tuning system. The resulting device is compact and extremely stable, and efficiently
converts inexpensive near-infrared (NIR) light into coherent UVA. UVALITH will advance this recently-patented technology
from the laboratory proof-of-principle stage to a technology level suitable for uptake by industrial and commercial actors,
including advances in scalability, versatility and reliability.
(Quantum Simulation of Insulators and Conductors) toward industrial and biomedical use. Optical frequency converters use
nonlinear optical processes such as second harmonic generation to produce coherent light at wavelengths that are not
available, or not efficient, with existing laser sources. Importantly, optical frequency converters can reach near-ultraviolet
(UVA) wavelengths, employed in biological and medical applications based on fluorescent biomarkers. In QUIC, we have
developed a monolithic frequency converter, in which a single nonlinear optical crystal acts simultaneously as an optical
resonator, frequency converter, and tuning system. The resulting device is compact and extremely stable, and efficiently
converts inexpensive near-infrared (NIR) light into coherent UVA. UVALITH will advance this recently-patented technology
from the laboratory proof-of-principle stage to a technology level suitable for uptake by industrial and commercial actors,
including advances in scalability, versatility and reliability.
Unfold all
/
Fold all
More information & hyperlinks
| Web resources: | https://cordis.europa.eu/project/id/800901 |
| Start date: | 01-08-2018 |
| End date: | 31-01-2020 |
| Total budget - Public funding: | 140 416,25 Euro - 98 958,00 Euro |
Cordis data
Original description
UVALITH proposes to advance optical frequency conversion technology developed for the FET Proactive project QUIC(Quantum Simulation of Insulators and Conductors) toward industrial and biomedical use. Optical frequency converters use
nonlinear optical processes such as second harmonic generation to produce coherent light at wavelengths that are not
available, or not efficient, with existing laser sources. Importantly, optical frequency converters can reach near-ultraviolet
(UVA) wavelengths, employed in biological and medical applications based on fluorescent biomarkers. In QUIC, we have
developed a monolithic frequency converter, in which a single nonlinear optical crystal acts simultaneously as an optical
resonator, frequency converter, and tuning system. The resulting device is compact and extremely stable, and efficiently
converts inexpensive near-infrared (NIR) light into coherent UVA. UVALITH will advance this recently-patented technology
from the laboratory proof-of-principle stage to a technology level suitable for uptake by industrial and commercial actors,
including advances in scalability, versatility and reliability.
Status
CLOSEDCall topic
FETOPEN-04-2016-2017Update Date
27-04-2024
Images
No images available.
Geographical location(s)
